**Abstract**

It was reported the unconjugated bilirubin may be associated with neurotoxicity in the developing nervous system. And it is also reported that neonatal hyperbilirubinemia might be a vulnerability factor for the development of mental disorders.

Individuals with schizophrenia show a significantly higher frequency of hyperbilirubinemia relative to patients with other psychiatric disorders and the general healthy population. We have also observed that patients with schizophrenia frequently have an elevated bilirubin plasma concentration on admission to the hospital.

There have been reports of a positive relationship between schizophrenia and hyperbilirubinemia. We assume that a high serum unconjugated bilirubin concentration has a pathogenic effect on the development of the brain and consequently the behavioral abnormalities of schizophrenia.

The Gunn rat, a mutant of the Wistar strain, which has been used in several previous studies as an animal model of bilirubin encephalopathy. The Gunn rat has a genetic deficiency in glucuronyltransferase then revealed hyperbilirubinemia. Some Gunn rats have many of the same neurological symptoms and histopathological lesions that are exhibited by hyperbilirubinemic human newborns. It has been reported that the neural damage in Gunn rats almost always occurs in the first month after birth.

We assumed Gunn rats as one of the schizophrenia animal models. To validate as the schizophrenia model, we examined the acute behavioral abnormalities of Gunn rats and Wistar rats, after injection of NMDA-antagonist ketamine.

The locomotor stimulatory effect of ketamine was significantly greater in Gunn rats compared with Wistar rats, and furthermore interfered PPI after ketamine injection were observed in Gunn rats.

Gunn rats were more vulnerable to ketamine than Wistar rats.

The results related to the face, predictive and construct validities.
